Regulation of CDK9 activity by phosphorylation and dephosphorylation

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Nekhai, Sergei ^a   Petukhov, Michael ^b,c   Breuer, Denitra ^a  

^a HOWARD UNIVERSITY   (United States)

^b PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^c PETER THE GREAT ST PETERSBURG POLYTECHNIC UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9;

GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; VIROLOGY;

CYCLIN-DEPENDENT KINASE 9; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PHOSPHORYLATION; TRANSCRIPTION, GENETIC;

EID: 84893776798     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/964964     Document Type: Review

References (80)

1. Lafeuillade A., Stevenson M., The search for a cure for persistent HIV reservoirs. AIDS Reviews 2011 13 2 63 66 2-s2.0-80053062468
2. Choudhary S. K., Margolis D. M., Curing HIV: pharmacologic approaches to target HIV-1 latency. Annual Review of Pharmacology and Toxicology 2011 51 397 418 2-s2.0-79951990287 10.1146/annurev-pharmtox-010510-100237
3. Lu H., Li Z., Xue Y., Zhou Q., Viral-host interactions that control HIV-1 transcriptional elongation. Chemical Reviews 2013 113 11 8567 8582 10.1021/cr400120z
4. Watanabe Y., Fujimoto H., Watanabe T., Maekawa T., Masutani C., Hanaoka F., Ohkuma Y., Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II. Genes to Cells 2000 5 5 407 423 2-s2.0-0034086404 10.1046/j.1365-2443.2000. 00336.x (Pubitemid 30409096)
5. Ping Y.-H., Rana T. M., DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. The Journal of Biological Chemistry 2001 276 16 12951 12958 2-s2.0-0035918157 10.1074/jbc.M006130200
6. Akhtar M. S., Heidemann M., Tietjen J. R., Zhang D. W., Chapman R. D., Eick D., Ansari A. Z., TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Molecular Cell 2009 34 3 387 393 2-s2.0-65549156025 10.1016/j.molcel.2009.04.016
7. Czudnochowski N., Bösken C. A., Geyer M., Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nature Communications 2012 3, article 842 10.1038/ncomms1846
8. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A., A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998 92 4 451 462 2-s2.0-0032548918 10.1016/S0092-8674(00)80939-3 (Pubitemid 28101109)
9. Peterlin B. M., Price D. H., Controlling the elongation phase of transcription with P-TEFb. Molecular Cell 2006 23 3 297 305 2-s2.0-33746403681 10.1016/j.molcel.2006.06.014 (Pubitemid 44128850)
10. Brès V., Yoh S. M., Jones K. A., The multi-tasking P-TEFb complex. Current Opinion in Cell Biology 2008 20 3 334 340 2-s2.0-44649154972 10.1016/j.ceb.2008.04.008
11. Yamada T., Yamaguchi Y., Inukai N., Okamoto S., Mura T., Handa H., P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Molecular Cell 2006 21 2 227 237 2-s2.0-30744449491 10.1016/j.molcel.2005.11.024 (Pubitemid 43099938)
12. Marshall N. F., Peng J., Xie Z., Price D. H., Control of RNA polymerase II elongation potential by a novel carboxyl- terminal domain kinase. The Journal of Biological Chemistry 1996 271 43 27176 27183 2-s2.0-0029959881 10.1074/jbc.271.43.27176 (Pubitemid 26359140)
13. Peng J., Zhu Y., Milton J. T., Price D. H., Identification of multiple cyclin subunits of human P-TEFb. Genes & Development 1998 12 5 755 762 2-s2.0-0032031706 (Pubitemid 28134306)
14. Edwards M. C., Wong C., Elledge S. J., Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity. Molecular and Cellular Biology 1998 18 7 4291 4300 2-s2.0-0031834340 (Pubitemid 28287952)
15. Kohoutek J., Blazek D., Cyclin K goes with Cdk12 and Cdk13. Cell Division 2012 7, article 12 2-s2.0-84859791205 10.1186/1747-1028-7-12
16. Blazek D., The cyclin K/Cdk12 complex: an emerging new player in the maintenance of genome stability. Cell Cycle 2012 11 6 1049 1050 2-s2.0-84858726608 10.4161/cc.11.6.19678
17. Ivanov D., Kwak Y. T., Nee E., Guo J., García-Martínez L. F., Gaynor R. B., Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat -activation. Journal of Molecular Biology 1999 288 1 41 56 2-s2.0-0033597175 10.1006/jmbi.1999.2663 (Pubitemid 29201503)
18. Garber M. E., Wei P., KewalRamani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A., The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes & Development 1998 12 22 3512 3527 2-s2.0-0032533253 (Pubitemid 28553243)
19. Kwak Y. T., Ivanov D., Guo J., Nee E., Gaynor R. B., Role of the human and murine cyclin T proteins in regulating HIV-1 tat -activation. Journal of Molecular Biology 1999 288 1 57 69 2-s2.0-0033597346 10.1006/jmbi.1999.2664 (Pubitemid 29201504)
20. Bieniasz P. D., Grdina T. A., Bogerd H. P., Cullen B. R., Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. The EMBO Journal 1998 17 23 7056 7065 2-s2.0-0032401752 (Pubitemid 28550299)
21. Shore S. M., Byers S. A., Dent P., Price D. H., Characterization of Cdk955 and differential regulation of two Cdk9 isoforms. Gene 2005 350 1 51 58 2-s2.0-17044433094 10.1016/j.gene.2005.01.015
22. Kohoutek J., P-TEFb- the final frontier. Cell Division 2009 4, article 19 2-s2.0-71049193792 10.1186/1747-1028-4-19
23. Yang Z., Zhu Q., Luo K., Zhou Q., The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 2001 414 6861 317 322 2-s2.0-0035891271 10.1038/35104575 (Pubitemid 33097809)
24. Nguyen V. T., Kiss T., Michels A. A., Bensaude O., 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 2001 414 6861 322 325 2-s2.0-0035891288 10.1038/35104581 (Pubitemid 33097810)
25. De Clercq E., New developments in anti-HIV chemotherapy. Biochimica et Biophysica Acta 2002 1587 2-3 258 275 2-s2.0-0037130296 10.1016/S0925-4439(02) 00089-3 (Pubitemid 34655794)
26. Yik J. H., Chen R., Nishimura R., Jennings J. L., Link A. J., Zhou Q., Inhibition of P-TEFb (CDK9/cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Molecular Cell 2003 12 4 971 982 2-s2.0-0242361319 10.1016/S1097-2765(03)00388-5 (Pubitemid 37352789)
27. Krueger B. J., Jeronimo C., Roy B. B., Bouchard A., Barrandon C., Byers S. A., Searcey C. E., Cooper J. J., Bensaude O., Cohen É. A., Coulombe B., Price D. H., LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Research 2008 36 7 2219 2229 2-s2.0-42449086866 10.1093/nar/gkn061 (Pubitemid 351566996)
28. Markert A., Grimm M., Martinez J., Wiesner J., Meyerhans A., Meyuhas O., Sickmann A., Fischer U., The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Reports 2008 9 6 569 575 2-s2.0-44649135099 10.1038/embor.2008.72 (Pubitemid 351772921)
29. He N., Jahchan N. S., Hong E., Li Q., Bayfield M. A., Maraia R. J., Luo K., Zhou Q., A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis. Molecular Cell 2008 29 5 588 599 2-s2.0-40649100262 10.1016/j.molcel.2008.01.003
30. Bayfield M. A., Yang R., Maraia R. J., Conserved and divergent features of the structure and function of La and La-related proteins (LARPs). Biochimica et Biophysica Acta 2010 1799 5-6 365 378 2-s2.0-77953694873 10.1016/j.bbagrm. 2010.01.011
31. Xue Y., Yang Z., Chen R., Zhou Q., A capping-independent function of MePCE in stabilizing 7SK snRNA and facilitating the assembly of 7SK snRNP. Nucleic Acids Research 2009 38 2 360 369 2-s2.0-77449119756 10.1093/nar/gkp977
32. Barboric M., Lenasi T., Chen H., Johansen E. B., Guo S., Peterlin B. M., 7SK snRNP/P-TEFb couples transcription elongation with alternative splicing and is essential for vertebrate development. Proceedings of the National Academy of Sciences of the United States of America 2009 106 19 7798 7803 2-s2.0-66049098191 10.1073/pnas.0903188106
33. Jeronimo C., Forget D., Bouchard A., Li Q., Chua G., Poitras C., Thérien C., Bergeron D., Bourassa S., Greenblatt J., Chabot B., Poirier G. G., Hughes T. R., Blanchette M., Price D. H., Coulombe B., Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Molecular Cell 2007 27 2 262 274 2-s2.0-34447321025 10.1016/j.molcel.2007.06.027 (Pubitemid 47058308)
34. Michels A. A., Fraldi A., Li Q., Adamson T. E., Bonnet F., Nguyen V. T., Sedore S. C., Price J. P., Price D. H., Lania L., Bensaude O., Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. The EMBO Journal 2004 23 13 2608 2619 2-s2.0-3342967685 10.1038/sj.emboj.7600275 (Pubitemid 38988232)
35. Sedore S. C., Byers S. A., Biglione S., Price J. P., Maury W. J., Price D. H., Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR. Nucleic Acids Research 2007 35 13 4347 4358 2-s2.0-34547850648 10.1093/nar/gkm443 (Pubitemid 47244588)
36. Yang Z., Yik J. H., Chen R., He N., Jang M. K., Ozato K., Zhou Q., Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Molecular Cell 2005 19 4 535 545 2-s2.0-23744467035 10.1016/j.molcel.2005.06.029 (Pubitemid 41140010)
37. Jang M. K., Mochizuki K., Zhou M., Jeong H.-S., Brady J. N., Ozato K., The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Molecular Cell 2005 19 4 523 534 2-s2.0-23744514308 10.1016/j.molcel.2005.06.027 (Pubitemid 41140009)
38. Barboric M., Yik J. H., Czudnochowski N., Yang Z., Chen R., Contreras X., Geyer M., Peterlin B. M., Zhou Q., Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Research 2007 35 6 2003 2012 2-s2.0-34247874793 10.1093/nar/gkm063 (Pubitemid 47061666)
39. Muniz L., Egloff S., Ughy B., Jády B. E., Kiss T., Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator tat. PLoS Pathogens 2010 6 10, article e1001152 2-s2.0-78449234720 10.1371/journal.ppat. 1001152
40. D'Orso I., Frankel A. D., HIV-1 Tat: its dependence on host factors is crystal clear. Viruses 2010 2 10 2226 2234 2-s2.0-79952137669 10.3390/v2102226
41. Sobhian B., Laguette N., Yatim A., Nakamura M., Levy Y., Kiernan R., Benkirane M., HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Molecular Cell 2010 38 3 439 451 2-s2.0-77951954237 10.1016/j.molcel.2010.04.012
42. He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N. J., Alber T., Zhou Q., HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Molecular Cell 2010 38 3 428 438 2-s2.0-77951959240 10.1016/j.molcel.2010.04.013
43. Chou S., Upton H., Bao K., Schulze-Gahmen U., Samelson A. J., He N., Nowak A., Lu H., Krogan N. J., Zhou Q., Alber T., HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold. Proceedings of the National Academy of Sciences of the United States of America 2013 110 2 E123 E131 10.1073/pnas.1216971110
44. Shilatifard A., Lane W. S., Jackson K. W., Conaway R. C., Conaway J. W., An RNA polymerase II elongation factor encoded by the human ELL gene. Science 1996 271 5257 1873 1876 2-s2.0-0029879664 (Pubitemid 26112315)
45. Garber M. E., Mayall T. P., Suess E. M., Meisenhelder J., Thompson N. E., Jones K. A., CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Molecular and Cellular Biology 2000 20 18 6958 6969 2-s2.0-0033817555 10.1128/MCB.20.18.6958- 6969.2000
46. Baumli S., Lolli G., Lowe E. D., Troiani S., Rusconi L., Bullock A. N., Debreczeni J. É., Knapp S., Johnson L. N., The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. The EMBO Journal 2008 27 13 1907 1918 2-s2.0-46949093191 10.1038/emboj.2008.121
47. Ammosova T., Washington K., Debebe Z., Brady J., Nekhai S., Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-I in Tat-activated HIV-I transcription. Retrovirology 2005 2, article 47 2-s2.0-27344456057 10.1186/1742-4690-2-47 (Pubitemid 41522416)
48. Zhou M., Nekhai S., Bharucha D. C., Kumar A., Ge H., Price D. H., Egly J.-M., Brady J. N., TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. The Journal of Biological Chemistry 2001 276 48 44633 44640 2-s2.0-0035976987 10.1074/jbc.M107466200
49. Zhou M., Huang K., Jung K.-J., Cho W.-K., Klase Z., Kashanchi F., Pise-Masison C. A., Brady J. N., Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. Journal of Virology 2009 83 2 1036 1044 2-s2.0-58149487612 10.1128/JVI.01316-08
50. Epie N., Ammosova T., Turner W., Nekhai S., Inhibition of PP2A by LIS1 increases HIV-1 gene expression. Retrovirology 2006 3, article 65 2-s2.0-33750209784 10.1186/1742-4690-3-65 (Pubitemid 44604854)
51. Epie N., Ammosova T., Sapir T., Voloshin Y., Lane W. S., Turner W., Reiner O., Nekhai S., HIV-1 Tat interacts with LIS1 protein. Retrovirology 2005 2, article 6 2-s2.0-18144401704 10.1186/1742-4690-2-6 (Pubitemid 40617974)
52. Zhou M., Lu H., Park H., Wilson-Chiru J., Linton R., Brady J. N., Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription. Journal of Virology 2006 80 10 4781 4791 2-s2.0-33646463585 10.1128/JVI.80.10.4781-4791.2006
53. + T lymphocytes. PLoS Pathogens 2013 9 5, article e1003338 10.1371/journal.ppat.1003338
54. Gu Y., Rosenblatt J., Morgan D. O., Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. The EMBO Journal 1992 11 11 3995 4005 2-s2.0-0026713875
55. Krek W., Nigg E. A., Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites. The EMBO Journal 1991 10 2 305 316 2-s2.0-0026027660 (Pubitemid 21905480)
56. Ammosova T., Obukhov Y., Kotelkin A., Breuer D., Beullens M., Gordeuk V. R., Bollen M., Nekhai S., Protein phosphatase-1 activates CDK9 by dephosphorylating ser175. PLoS ONE 2011 6 4, article e18985 2-s2.0-79955382495 10.1371/journal.pone.0018985
57. Chen R., Yang Z., Zhou Q., Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. The Journal of Biological Chemistry 2004 279 6 4153 4160 2-s2.0-1042289789 10.1074/jbc.M310044200 (Pubitemid 38199000)
58. Li Q., Price J. P., Byers S. A., Cheng D., Peng J., Price D. H., Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. The Journal of Biological Chemistry 2005 280 31 28819 28826 2-s2.0-23344437022 10.1074/jbc.M502712200 (Pubitemid 41105784)
59. Russo A. A., Jeffrey P. D., Pavletich N. P., Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature Structural Biology 1996 3 8 696 700 2-s2.0-0029767016 10.1038/nsb0896-696 (Pubitemid 26260060)
60. Larochelle S., Amat R., Glover-Cutter K., Sanso M., Zhang C., Allen J. J., Shokat K. M., Bentley D. L., Fisher R. P., Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nature Structural & Molecular Biology 2012 19 11 1108 1115 10.1038/nsmb.2399
61. Fisher R. P., The CDK network: linking cycles of cell division and gene expression. Genes & Cancer 2012 3 11-12 731 738 10.1177/1947601912473308
62. Ramakrishnan R., Rice A. P., Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway. Journal of Cellular Physiology 2012 227 2 609 617 2-s2.0-81755184665 10.1002/jcp.22760
63. Bharucha D. C., Zhou M., Nekhai S., Brady J. N., Shukla R. R., Kumar A., A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat. Virology 2002 296 1 6 16 2-s2.0-0036348916 10.1006/viro.2002.1438
64. Ammosova T., Jerebtsova M., Beullens M., Voloshin Y., Ray P. E., Kumar A., Bollen M., Nekhai S., Nuclear protein phosphatase-1 regulates HIV-1 transcription. The Journal of Biological Chemistry 2003 278 34 32189 32194 2-s2.0-0042858144 10.1074/jbc.M300521200 (Pubitemid 37048410)
65. Ammosova T., Jerebtsova M., Beullens M., Lesage B., Jackson A., Kashanchi F., Southerland W., Gordeuk V. R., Bollen M., Nekhai S., Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. The Journal of Biological Chemistry 2005 280 43 36364 36371 2-s2.0-27744597059 10.1074/jbc.M503673200 (Pubitemid 41633910)
66. 2+ signaling. Genes & Development 2008 22 10 1356 1368 10.1101/gad.1636008 (Pubitemid 351717526)
67. Ammosova T., Yedavalli V. R., Niu X., Jerebtsova M., Van Eynde A., Beullens M., Bollen M., Jeang K.-T., Nekhai S., Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription. The Journal of Biological Chemistry 2011 286 5 3798 3804 2-s2.0-79952782278 10.1074/jbc.M110.196493
68. Wang Y., Dow E. C., Liang Y.-Y., Ramakrishnan R., Liu H., Sung T.-L., Lin X., Rice A. P., Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop. The Journal of Biological Chemistry 2008 283 48 33578 33584 2-s2.0-57749098792 10.1074/jbc.M807495200
69. + T cells. Journal of Virology 2013 87 2 1211 1220 10.1128/JVI.02413-12
70. Ammosova T., Platonov M., Yedavalli V. R. K., Obukhov Y., Gordeuk V. R., Jeang K. T., Kovalskyy D., Nekhai S., Small molecules targeted to a non-catalytic, "RVxF" binding site of protein phosphatase-1 inhibit HIV-1. PLoS ONE 2012 7 6, article e39481 10.1371/journal.pone.0039481
71. Kashanchi F., Agbottah E. T., Pise-Masison C. A., Mahieux R., Duvall J., Kumar A., Brady J. N., Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator. Journal of Virology 2000 74 2 652 660 2-s2.0-0033987568 10.1128/JVI.74.2.652-660.2000 (Pubitemid 30036200)
72. Nekhai S., Shukla R. R., Fernandez A., Kumar A., Lamb N. J., Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator. Virology 2000 266 2 246 256 2-s2.0-0034688295 10.1006/viro.1999.0035 (Pubitemid 30070629)
73. Deng L., Ammosova T., Pumfery A., Kashanchi F., Nekhai S., HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter. The Journal of Biological Chemistry 2002 277 37 33922 33929 2-s2.0-0037072781 10.1074/jbc.M111349200
74. Nekhai S., Zhou M., Fernandez A., Lane W. S., Lamb N. J., Brady J., Kumar A., HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription. Biochemical Journal 2002 364, part 3 649 657 2-s2.0-0037096976 10.1042/BJ20011191 (Pubitemid 34680840)
75. Ammosova T., Berro R., Kashanchi F., Nekhai S., RNA interference directed to CDK2 inhibits HIV-1 transcription. Virology 2005 341 2 171 178 2-s2.0-26244436628 10.1016/j.virol.2005.06.041 (Pubitemid 41416727)
76. Jerebtsova M., Kumari N., Xu M., de Melo G. B. A., Niu X., Jeang K. T., Nekhai S., HIV-1 resistant CDK2-knockdown macrophage-like cells generated from 293T cell-derived human induced pluripotent stem cells. Biology 2012 1 2 175 195 10.3390/biology1020175
77. Debebe Z., Ammosova T., Jerebtsova M., Kurantsin-Mills J., Niu X., Charles S., Richardson D. R., Ray P. E., Gordeuk V. R., Nekhai S., Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology 2007 367 2 324 333 2-s2.0-34848927142 10.1016/j.virol.2007.06.011 (Pubitemid 47494537)
78. Debebe Z., Ammosova T., Breuer D., Lovejoy D. B., Kalinowski D. S., Kumar K., Jerebtsova M., Ray P., Kashanchi F., Gordeuk V. R., Richardson D. R., Nekhai S., Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets-iron, cyclin-dependent kinase (CDK) 2, and CDK9. Molecular Pharmacology 2011 79 1 185 196 2-s2.0-81555210947 10.1124/mol.80.6.1190
79. Semenza G. L., Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE 2007 2007 407, article cm8 2-s2.0-35148828429 10.1126/stke.4072007cm8
80. Breuer D., Kotelkin A., Ammosova T., Kumari N., Ivanov A., Ilatovskiy A. V., Beullens M., Roane P. R., Bollen M., Petukhov M. G., Kashanchi F., Nekhai S., CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90. Retrovirology 2012 9, article 94 10.1186/1742-4690-9-94